Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eleven Biotherapeutics, Inc. | 85,000 | reported | 17 Jun 2024 | tx 4+824,614 |
| VIROPHARMA INC | 6,000 | reported | 04 Jun 2012 | tx 32+75,100−48,400 |
| Passage BIO, Inc. | 5,454 | reported | 21 May 2021 | tx 4+126,882 |
| Vitae Pharmaceuticals, Inc | 0 | reported | 25 Oct 2016 | tx 11+85,828−238,001 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2024 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 85,000 | 0.00 USD | deriv |
| 31 Jan 2024 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 170,500 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 238,000 | 0.00 USD | deriv |
| 07 Mar 2023 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 331,114 | — | deriv |
| 21 May 2021 | PURCHASE | Passage BIO, Inc. | 2,171 | 13.82 USD | first after silence |
| 16 Feb 2021 | GRANT_AWARD | Passage BIO, Inc. | 50,000 | 0.00 USD | deriv |
| 03 Mar 2020 | PURCHASE | Passage BIO, Inc. | 400 | 18.00 USD | |
| 27 Feb 2020 | GRANT_AWARD | Passage BIO, Inc. | 74,311 | 0.00 USD | deriv |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 828 | 21.00 USD | |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 27,500 | 12.42 USD | deriv |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 27,500 | 12.22 USD | deriv |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 15,000 | 12.72 USD | deriv |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 152,173 | 15.71 USD | deriv |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 15,000 | 6.60 USD | deriv |
| 29 Apr 2016 | GRANT_AWARD | Vitae Pharmaceuticals, Inc | 828 | 6.11 USD | |
| 15 Aug 2016 | GRANT_AWARD | Vitae Pharmaceuticals, Inc | 27,500 | 0.00 USD | deriv |
| 15 Feb 2016 | GRANT_AWARD | Vitae Pharmaceuticals, Inc | 27,500 | 0.00 USD | deriv |
| 14 Aug 2015 | GRANT_AWARD | Vitae Pharmaceuticals, Inc | 15,000 | 0.00 USD | deriv |
| 13 Feb 2015 | GRANT_AWARD | Vitae Pharmaceuticals, Inc | 15,000 | 0.00 USD | deriv |
| 04 Jun 2012 | GRANT_AWARD | VIROPHARMA INC | 6,000 | — | deriv |
| 09 Mar 2012 | SALE | VIROPHARMA INC | 1,300 | 29.71 USD | |
| 09 Mar 2012 | EXERCISE | VIROPHARMA INC | 1,300 | 7.05 USD | |
| 09 Mar 2012 | EXERCISE | VIROPHARMA INC | 1,300 | 0.00 USD | deriv |
| 05 Mar 2012 | EXERCISE | VIROPHARMA INC | 3,300 | 7.05 USD | |
| 05 Mar 2012 | EXERCISE | VIROPHARMA INC | 2,000 | 5.91 USD |
1 purchase reported after at least 12 months of silence — most recent on 21 May 2021.